Arkolith/Insider Trading/PYXS/Form 4

Sullivan Lara

President and CEO, DirectorPyxis Oncology, Inc. (PYXS) · full profile →Form 4 · filed Sep 18, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$18K
Net Open-Market Flow
-$18K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 18, 2023Sell(S)9K$2.10$18K2.4M
Sep 14, 2023Sell(S)100$2.25$2252.4M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-049826) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML